![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif) |
|
![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif)
dalteparin A low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, dalteparin binds to antithrombin and enhances the inhibition of Factor Xa. Compared to unfractionated heparins, the use of dalteparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)
![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif)
Synonym: | ![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif) | dalteparin sodium | | ![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif) | US brand name: | ![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif) | Fragmin | | ![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif) | Abbreviation: | ![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif) | DAL | | ![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif) |
![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif)
![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/gray_spacer.gif)
![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif)
|
![](https://webarchive.library.unt.edu/web/20090114221414im_/http://www.cancer.gov/images/spacer.gif) |